Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status and new help sections were added, including How to Read a Study Record, Common Questions, and How to Join a Study; the Intervention/Treatment heading was added, while some related topics and the Lung Cancer label were removed, and the page was updated to revision v3.6.0.SummaryDifference0.6%

- Check16 days agoChange DetectedA Lung cancer topic tag and a related MedlinePlus Genetics link were added, and the revision version was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check23 days agoChange DetectedRemoved the 'Lung cancer' keyword and the 'MedlinePlus Genetics' entry from the related topics section. The related topics header was also removed, reducing cross-links to external resources.SummaryDifference0.2%

- Check31 days agoChange DetectedExpanded the MedlinePlus related topics to include Lung cancer and MedlinePlus Genetics, broadening the educational resources linked from the study page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page shows a new site revision label (Revision: v3.5.4) alongside removals of certain navigation topics (Lung cancer, related topics:, MedlinePlus Genetics) and an older revision note (Revision: v3.5.3); these are metadata updates to the site and do not affect the study data.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded Lung cancer as a topic tag and MedlinePlus Genetics as a related topic; updated the page revision to v3.5.3, replacing v3.5.2.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.